Rasburicase 1.5mg Injection for Tumor Lysis Syndrome Management
Rasburicase 1.5mg Injection is a recombinant urate oxidase formulation widely used in oncology supportive care for managing elevated uric acid levels associated with chemotherapy-induced tumor lysis syndrome (TLS). The product is commonly supplied as a lyophilized powder for intravenous administration and requires cold-chain handling during storage and transportation.
Product Overview
Generic Name: Rasburicase
Strength: 1.5 mg Injection
Dosage Form: Lyophilized Powder for Injection
Route of Administration: Intravenous Infusion
Therapeutic Category: Oncology Supportive Care / Anti-Hyperuricemic Agent
Storage Conditions: Store at 2°C–8°C, protect from freezing and light.
Packaging: Single-dose vial options available depending on market requirements
Export Availability: Global supply for regulated and semi-regulated markets
What is Rasburicase 1.5mg Injection Used For?
Rasburicase is indicated for the management of elevated plasma uric acid levels associated with tumor lysis syndrome in patients receiving anticancer treatment. It works by converting uric acid into allantoin, which is more soluble and easier to eliminate from the body.
Key Benefits
✔ Rapid reduction of uric acid levels
✔ Used in oncology supportive therapy protocols
✔ Suitable for hospital and institutional procurement channels
✔ Available for global pharmaceutical distribution networks
✔ Supports oncology treatment infrastructure requirements
Mechanism of Action
Rasburicase is a recombinant urate oxidase enzyme that catalyzes the oxidation of uric acid into allantoin, helping reduce uric acid accumulation associated with rapid tumor cell breakdown.
Global Export Supply & International Distribution
We support international pharmaceutical procurement and export operations with:
Oncology injectable export solutions
Bulk pharmaceutical supply capabilities
Cold-chain pharmaceutical logistics support
Contract manufacturing opportunities
Third-party manufacturing support
Private labeling options
Hospital tender participation support
Distributor and importer partnerships
Export Markets Served
Middle East Pharmaceutical Markets
Africa Pharma Distribution Networks
Southeast Asia Healthcare Procurement
Latin America Pharmaceutical Supply Chains
CIS Countries
Europe & International Institutional Buyers
Quality & Compliance Focus
Manufactured under stringent quality systems
Documentation support for international shipments
Batch traceability and quality assurance processes
Export documentation assistance available
Regulatory support for international buyers
Why Choose Our Rasburicase 1.5mg Injection Supply Solutions?
Our pharmaceutical export network supports distributors, importers, hospitals, government tenders, and oncology procurement agencies seeking reliable sourcing for specialty injectable medicines.
Request Product Details
Contact our export team for:
Product specifications
Certificate availability
MOQ requirements
Pricing quotations
Country-specific registration support
Distribution partnerships
Looking for a reliable Rasburicase 1.5mg Injection manufacturer, supplier, or exporter? Connect with our global pharmaceutical team for procurement support and international supply solutions.
Rasburicase 1.5mg Injection is a recombinant urate oxidase formulation widely used in oncology supportive care for managing elevated uric acid levels associated with chemotherapy-induced tumor lysis syndrome (TLS). The product is commonly supplied as a lyophilized powder for intravenous administration and requires cold-chain handling during storage and transportation.
Product Overview
Generic Name: Rasburicase
Strength: 1.5 mg Injection
Dosage Form: Lyophilized Powder for Injection
Route of Administration: Intravenous Infusion
Therapeutic Category: Oncology Supportive Care / Anti-Hyperuricemic Agent
Storage Conditions: Store at 2°C–8°C, protect from freezing and light.
Packaging: Single-dose vial options available depending on market requirements
Export Availability: Global supply for regulated and semi-regulated markets
What is Rasburicase 1.5mg Injection Used For?
Rasburicase is indicated for the management of elevated plasma uric acid levels associated with tumor lysis syndrome in patients receiving anticancer treatment. It works by converting uric acid into allantoin, which is more soluble and easier to eliminate from the body.
Key Benefits
✔ Rapid reduction of uric acid levels
✔ Used in oncology supportive therapy protocols
✔ Suitable for hospital and institutional procurement channels
✔ Available for global pharmaceutical distribution networks
✔ Supports oncology treatment infrastructure requirements
Mechanism of Action
Rasburicase is a recombinant urate oxidase enzyme that catalyzes the oxidation of uric acid into allantoin, helping reduce uric acid accumulation associated with rapid tumor cell breakdown.
Global Export Supply & International Distribution
We support international pharmaceutical procurement and export operations with:
Oncology injectable export solutions
Bulk pharmaceutical supply capabilities
Cold-chain pharmaceutical logistics support
Contract manufacturing opportunities
Third-party manufacturing support
Private labeling options
Hospital tender participation support
Distributor and importer partnerships
Export Markets Served
Middle East Pharmaceutical Markets
Africa Pharma Distribution Networks
Southeast Asia Healthcare Procurement
Latin America Pharmaceutical Supply Chains
CIS Countries
Europe & International Institutional Buyers
Quality & Compliance Focus
Manufactured under stringent quality systems
Documentation support for international shipments
Batch traceability and quality assurance processes
Export documentation assistance available
Regulatory support for international buyers
Why Choose Our Rasburicase 1.5mg Injection Supply Solutions?
Our pharmaceutical export network supports distributors, importers, hospitals, government tenders, and oncology procurement agencies seeking reliable sourcing for specialty injectable medicines.
Request Product Details
Contact our export team for:
Product specifications
Certificate availability
MOQ requirements
Pricing quotations
Country-specific registration support
Distribution partnerships
Looking for a reliable Rasburicase 1.5mg Injection manufacturer, supplier, or exporter? Connect with our global pharmaceutical team for procurement support and international supply solutions.
Keywords
